Relapsed and/or Refractory Multiple Myeloma (RRMM) Clinical Trials in Southport, Queensland

A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)